Clinical trials
Withdrawn Phase 2 Stomach Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 1 |
| Bristol-Myers Squibb | 1 |
| Ellipses Pharma | 1 |
| Erasmus Medical Center | 1 |
| Fuda Cancer Hospital, Guangzhou | 1 |
| ImmunoGen, Inc. | 1 |
| Korean South West Oncology Group | 1 |
| M.D. Anderson Cancer Center | 1 |
| Massachusetts General Hospital | 1 |
| Peking University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 15 |
| Adenocarcinoma | 2 |
| Breast Neoplasms | 2 |
| Head and Neck Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Small Cell Lung Carcinoma | 2 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Endophthalmitis | 1 |
| Esophageal Neoplasms | 1 |
| Hodgkin Disease | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.